tiprankstipranks
Alterity Therapeutics Reports Positive Phase 2 Trial Results for MSA Treatment
PremiumCompany AnnouncementsAlterity Therapeutics Reports Positive Phase 2 Trial Results for MSA Treatment
1M ago
Alterity Therapeutics reports cash balance of A$17.96M as of March 31
Premium
The Fly
Alterity Therapeutics reports cash balance of A$17.96M as of March 31
1M ago
Alterity Therapeutics Announces Director Securities Changes
Premium
Company Announcements
Alterity Therapeutics Announces Director Securities Changes
1M ago
Alterity Therapeutics Completes Key Phase 2 Trial for MSA Treatment
PremiumCompany AnnouncementsAlterity Therapeutics Completes Key Phase 2 Trial for MSA Treatment
3M ago
Alterity Therapeutics Reports Progress and Financial Results
Premium
Company Announcements
Alterity Therapeutics Reports Progress and Financial Results
3M ago
Buy Rating for Alterity Therapeutics: Strong Financial Position and Promising Clinical Results
Premium
Ratings
Buy Rating for Alterity Therapeutics: Strong Financial Position and Promising Clinical Results
3M ago
Alterity Therapeutics Ltd (ADR) trading halted, news pending
PremiumThe FlyAlterity Therapeutics Ltd (ADR) trading halted, news pending
4M ago
Alterity Therapeutics downgraded to Hold from Speculative Buy at Benchmark
Premium
The Fly
Alterity Therapeutics downgraded to Hold from Speculative Buy at Benchmark
4M ago
Alterity Therapeutics price target raised to $12 from $8 at Maxim
Premium
The Fly
Alterity Therapeutics price target raised to $12 from $8 at Maxim
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100